2018 Speaking Faculty


Biosimilars Market Access & Commercialization Summit

Amal Agarwal
Amal Agarwal
Medical Director
Humana


John Alter
John Alter
Vice President, Patient and Health Impact
Pfizer Essential Health Business Unit


Fouad Atouf
Fouad Atouf
Vice President, Head of Biologics
U.S. Pharmacopeia


Photo Not Available
Charlie Barr
Chief Science Officer
BBCIC Research Consortium Academy of Managed Care Pharmacy (AMCP)


Penny Bemus
Penny Bemus
Senior Vice President, Business Development
Dohmen Life Science Services (DLSS)


Ana Cespedes
Ana Cespedes
Senior Vice President, Global Marketing and Strategy
EMD Serono, a company of MERCK KGaA


David Clough
David Clough, Ph.D
Shareholder
Polsinelli PC


Brian Davis
Brian Davis
Vice President of Contracting and Payer Access
DLSS


Rakesh Dixit
Rakesh Dixit, Ph.D., DABT
Vice President R&D, Global Head, Biologics Safety Assessment
Medimmune


Joseph P. Fuhr Jr.
Joseph P. Fuhr Jr., PhD
Professor Emeritus of Economics Widener University and Adjunct Faculty
College of Population Health Thomas Jefferson University


John Garcia
John Garcia
Global Commercial Excellence Lead
Alnylam


Stanislav Glezer
Stanislav Glezer, MD MBA
Chief Medical Officer
Adocia


Robert Goldberg
Robert Goldberg, PhD
President and Co-Founder
Center For Medicine in Public Interest


Chris Guinther
Chris Guinther
System Director, Managed Care Pharmacy Services
Mercy Health


Ann Hartry
Ann Hartry
VP, HEOR
Lundbeck


Photo Not Available
Chrys Kokino
Head Global Biologic Commercial
Mylan


Brian Martinson
Brian Martinson
Specialty Pharmacy Leader
Lediant Biosciences


Ed McAdam
Ed McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.


Lindsay McKenna
Lindsay McKenna
Associate Principal
McKinsey & Company


John Josef Molenda
John Josef Molenda, PhD
Partner, Steptoe & Johnson LLPM
Co-Chair, Healthcare & Life Sciences Industry Practice


Morgan Molloy
Morgan Molloy
Chief Commercial Officer
Enzyvant


Jose Ricardo Perez
Jose Ricardo Perez, US CDMA
Executive Medical Director of Medical Affairs
Exelixis


Edmund Pezalla
Edmund Pezalla
Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy
Aetna


Robert Popovian
Robert Popovian
Vice President, US Government Relations
Pfizer


Ashish Sagrolikar
Ashish Sagrolikar
VP, Commercial Transformation
GSK


Josh Sternberg
Josh Sternberg
Expert
McKinsey & Company


Grace-Marie Turner
Grace-Marie Turner
President
Galen Institute


Reg Waldeck
Reg Waldeck
Market Access Leader
Bayer


Amber Walker
Amber Walker
Director, Specialty Pharmacy Development-Rare and Orphan
Walgreens


Gillian Woollett
Gillian Woollett
Senior Vice President
Avalere Health


Photo Not Available
Tim Worrall, Ph.D
Shareholder, Chair, Biotechnology Patent Group
Polsinelli PC


Gergana Zlateva
Gergana Zlateva
Patient & Health Impact, Oncology Market Access Lead
Pfizer


Burt Zweigenhaft
Burt Zweigenhaft
President
National Association of Specialty Pharmacy


5th Annual Oncology Market Access & Commercialization Summit Speakers

Amal Agarwal
Amal Agarwal
Medical Director
Humana


John Alter
John Alter
Vice President, Patient and Health Impact
Pfizer Essential Health Business Unit


Alan Balch
Alan Balch, PhD
CEO
Patient Advocate Foundation


Penny Bemus
Penny Bemus
Senior Vice President, Business Development
Dohmen Life Science Services (DLSS)


Anna S. Cameron
Anna S. Cameron
Global Market Access and Healthcare Solutions Leader
GSK


Robert W. Carlson
Robert W. Carlson, MD
Chief Executive Officer
NCCN®


Kevin Cast
Kevin Cast
Partner
Archbow


Ana Cespedes
Ana Cespedes
Senior Vice President, Global Marketing and Strategy
EMD Serono, a company of MERCK KGaA


Cindy Chmielewski
Cindy Chmielewski
Patient Advocate
Patient Power


Brian Davis
Brian Davis
Vice President of Contracting and Payer Access
DLSS


Stanislav Glezer
Stanislav Glezer, MD MBA
Chief Medical Officer
Adocia


Robert Goldberg
Robert Goldberg, PhD
President and Co-Founder
Center For Medicine in Public Interest


Chris Guinther
Chris Guinther
System Director, Managed Care Pharmacy Services
Mercy Health


Ann Hartry
Ann Hartry
VP, HEOR
Lundbeck


Tony Hebden
Tony Hebden, PhD
Vice President, Health Economics and Outcomes Research
ABBVIE


Dawn Holcombe
Dawn Holcombe, MBA, FACMPE, ACHE
Director, Oncology Institute NAMCP
Executive Director, Connecticut Oncology Association


Mridula Iyer
Mridula Iyer, Ph.D.
General Manager, Precision Medicine
Quest Diagnostics


Patti Jewell
Patti Jewell
Director, Oncology Public Affairs
Pfizer


Ed McAdam
Ed McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.


Lindsay McKenna
Lindsay McKenna
Associate Principal
McKinsey & Company


Ellen Miller Sonet
Ellen Miller Sonet
Chief Strategy and Alliance Officer
CancerCare


Morgan Molloy
Morgan Molloy
Chief Commercial Officer
Enzyvant Therapeutics


Bob Orzechowski
Bob Orzechowski
CEO
Lancaster Cancer Center


Edmund Pezalla
Edmund Pezalla
Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy
Aetna


Osama Rahma
Osama Rahma, MD
Assistant Professor of Medicine
Center For Immuno-Oncology |Gastrointestinal Cancer Center
Dana-Farber Cancer Institute| Harvard Medical School


Ashish Sagrolikar
Ashish Sagrolikar
VP, Commercial Transformation
GSK


Kristen Santiago
Kristen Santiago
Senior Director, Policy & Advocacy
Cancer Support Community


Josh Sternberg
Josh Sternberg
Expert
McKinsey & Company


Stephanie Trunk
Stephanie Trunk
Partner
Arent Fox LLP


Grace-Marie Turner
Grace-Marie Turner
President
Galen Institute


Reg Waldeck
Reg Waldeck
Market Access Leader
Bayer


Gergana Zlateva
Gergana Zlateva
Patient & Health Impact, Oncology Market Access Lead
Pfizer


Burt Zweigenhaft
Burt Zweigenhaft
President
National Association of Specialty Pharmacy


Cell & Gene Therapy Commercialization Summit

Amal Agarwal
Amal Agarwal
Medical Director
Humana


John Alter
John Alter
Vice President, Patient and Health Impact
Pfizer Essential Health Business Unit


Priya R. Baraniak
Priya R. Baraniak, PhD
Director of Business Development & Strategic Marketing
Roosterbio Inc


Penny Bemus
Penny Bemus
Senior Vice President, Business Development
Dohmen Life Science Services (DLSS)


Kevin Cast
Kevin Cast
Partner
Archbow


Ana Cespedes
Ana Cespedes
Senior Vice President, Global Marketing and Strategy
EMD Serono, a company of MERCK KGaA


Stephen Chang
Stephen Chang
Senior Vice President for Strategic Research Initiatives
NY Stem Cell Foundation


Adam S Davis
Adam S Davis, Ph.D.
Director of Manufacturing
Abeona Therapeutics Inc.


Brian Davis
Brian Davis
Vice President of Contracting and Payer Access
DLSS


Michael DeRidder
Michael DeRidder, PhD
Senior Director, Early Pipeline Commercial Strategy, Oncology Cell Therapy, Global Specialty Franchise
GSK


Kimberly Freeman
Kimberly Freeman
Vice President, Commercial Strategy & Planning
Adaptimmune


Benjamin Fryer
Benjamin Fryer, PhD
Team Leader, Processing/Manufacturing, Heart Regeneration Program
University of Washington School of Medicine


Stanislav Glezer
Stanislav Glezer, MD MBA
Chief Medical Officer
Adocia


Robert Goldberg
Robert Goldberg, PhD
President and Co-Founder
Center For Medicine in Public Interest


Chris Guinther
Chris Guinther
System Director, Managed Care Pharmacy Services
Mercy Health


Ann Hartry
Ann Hartry
VP, HEOR
Lundbeck


Photo Not Available
Doug Jolly
Executive Vice President, Research and Pharmaceutical Development
Tocagen


Vikas Kundra
Vikas Kundra, MD, PhD
Director Molecular Imaging, Department of Radiology, M.D.
Anderson Cancer Center


Ed McAdam
Ed McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.


Lindsay McKenna
Lindsay McKenna
Associate Principal
McKinsey & Company


Morgan Molloy
Morgan Molloy
Chief Commercial Officer
Enzyvant Therapeutics


C. David Pauza
C. David Pauza, PhD
Chief Science Officer
American Gene Technologies


Edmund Pezalla
Edmund Pezalla
Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy
Aetna


Ashish Sagrolikar
Ashish Sagrolikar
VP, Commercial Transformation
GSK


Josh Sternberg
Josh Sternberg
Expert
McKinsey & Company


Lincoln Tsang
Lincoln Tsang, PhD
Partner, Life Science Practice
Arnold & Porter Kaye Scholer LLP


Grace-Marie Turner
Grace-Marie Turner
President
Galen Institute


Reg Waldeck
Reg Waldeck
Market Access Leader
Bayer


Gergana Zlateva
Gergana Zlateva
Patient & Health Impact, Oncology Market Access Lead
Pfizer


Burt Zweigenhaft
Burt Zweigenhaft
President
National Association of Specialty Pharmacy


5th Annual Rare Disease Market Access & Commercialization Summit

Amal Agarwal
Amal Agarwal
Medical Director
Humana


John Alter
John Alter
Vice President, Patient and Health Impact
Pfizer Essential Health Business Unit


Penny Bemus
Penny Bemus
Senior Vice President, Business Development
Dohmen Life Science Services (DLSS)


Kevin Cast
Kevin Cast
Partner
Archbow


Ana Cespedes
Ana Cespedes
Senior Vice President, Global Marketing and Strategy
EMD Serono, a company of MERCK KGaA


Brian Davis
Brian Davis
Vice President of Contracting and Payer Access
DLSS


Stanislav Glezer
Stanislav Glezer, MD MBA
Chief Medical Officer
Adocia


Robert Goldberg
Robert Goldberg, PhD
President and Co-Founder
Center For Medicine in Public Interest


Chris Guinther
Chris Guinther
System Director, Managed Care Pharmacy Services
Mercy Health


Ann Hartry
Ann Hartry
VP, HEOR
Lundbeck


Brian Malkin
Brian Malkin
FDA Counsel
Arent Fox LLP


Ed McAdam
Ed McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.


Lindsay McKenna
Lindsay McKenna
Associate Principal
McKinsey & Company


Christine McSherry
Christine McSherry
CEO
Jett Foundation


Morgan Molloy
Morgan Molloy
Chief Commercial Officer
Enzyvant Therapeutics


Linda Newberry-Ferguson
Linda Newberry-Ferguson
Senior Vice President, Clinical Navigation
Dohmen Life Science Services (DLSS)


Edmund Pezalla
Edmund Pezalla
Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy
Aetna


Jenny Robertson
Jenny Robertson
Chief Counsel, Rare Disease Group, Pfizer Innovative Health
Pfizer


Ashish Sagrolikar
Ashish Sagrolikar
VP, Commercial Transformation
GSK


Carey Stephenson
Carey Stephenson
Director, Commercial Insights
Dohmen Life Science Services (DLSS)


Josh Sternberg
Josh Sternberg
Expert
McKinsey & Company


Ravi Tayi
Ravi Tayi, MD, MPH
Chief Medical Officer
Ferring Pharmaceuticals


Grace-Marie Turner
Grace-Marie Turner
President
Galen Institute


Reg Waldeck
Reg Waldeck
Market Access Leader
Bayer